stockrowBlack Diamond Therapeutics, Inc. (BDTX) vs Outlook Therapeutics, Inc. (OTLK)
- Black Diamond Therapeutics, Inc. BDTX 1.72 +3.61%
- Outlook Therapeutics, Inc. OTLK 0.43 −2.27%
Black Diamond Therapeutics, Inc. and Outlook Therapeutics, Inc. are both Biotechnology companies. Outlook Therapeutics, Inc. is the larger, with a market value of $106.9M against $95.4M — 1.1× the size. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Black Diamond Therapeutics, Inc. leads on 6 and Outlook Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | BDTX | OTLK | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 195.62% | 65.16% |
| Operating margin | 0.00% | 4,781.76% | 0.00% |
| Net margin | 0.00% | 5,253.40% | 0.00% |
| Free cash flow margin | 0.00% | 4,826.38% | 0.00% |
| Return on equity | (37.21%) | 256.92% | (50.12%) |
| Return on assets | (29.21%) | (251.66%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack